Cargando…
A Large Retrospective Assessment of Voriconazole Exposure in Patients Treated with Extracorporeal Membrane Oxygenation
Background: Voriconazole is one of the first-line therapies for invasive pulmonary aspergillosis. Drug concentrations might be significantly influenced by the use of extracorporeal membrane oxygenation (ECMO). We aimed to assess the effect of ECMO on voriconazole exposure in a large patient populati...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303158/ https://www.ncbi.nlm.nih.gov/pubmed/34361978 http://dx.doi.org/10.3390/microorganisms9071543 |
_version_ | 1783727019611127808 |
---|---|
author | Van Daele, Ruth Bekkers, Britt Lindfors, Mattias Broman, Lars Mikael Schauwvlieghe, Alexander Rijnders, Bart Hunfeld, Nicole G. M. Juffermans, Nicole P. Taccone, Fabio Silvio Coimbra Sousa, Carlos Antônio Jacquet, Luc-Marie Laterre, Pierre-François Nulens, Eric Grootaert, Veerle Lyster, Haifa Reed, Anna Patel, Brijesh Meersseman, Philippe Debaveye, Yves Wauters, Joost Vandenbriele, Christophe Spriet, Isabel |
author_facet | Van Daele, Ruth Bekkers, Britt Lindfors, Mattias Broman, Lars Mikael Schauwvlieghe, Alexander Rijnders, Bart Hunfeld, Nicole G. M. Juffermans, Nicole P. Taccone, Fabio Silvio Coimbra Sousa, Carlos Antônio Jacquet, Luc-Marie Laterre, Pierre-François Nulens, Eric Grootaert, Veerle Lyster, Haifa Reed, Anna Patel, Brijesh Meersseman, Philippe Debaveye, Yves Wauters, Joost Vandenbriele, Christophe Spriet, Isabel |
author_sort | Van Daele, Ruth |
collection | PubMed |
description | Background: Voriconazole is one of the first-line therapies for invasive pulmonary aspergillosis. Drug concentrations might be significantly influenced by the use of extracorporeal membrane oxygenation (ECMO). We aimed to assess the effect of ECMO on voriconazole exposure in a large patient population. Methods: Critically ill patients from eight centers in four countries treated with voriconazole during ECMO support were included in this retrospective study. Voriconazole concentrations were collected in a period on ECMO and before/after ECMO treatment. Multivariate analyses were performed to evaluate the effect of ECMO on voriconazole exposure and to assess the impact of possible saturation of the circuit’s binding sites over time. Results: Sixty-nine patients and 337 samples (190 during and 147 before/after ECMO) were analyzed. Subtherapeutic concentrations (<2 mg/L) were observed in 56% of the samples during ECMO and 39% without ECMO (p = 0.80). The median trough concentration, for a similar daily dose, was 2.4 (1.2–4.7) mg/L under ECMO and 2.5 (1.4–3.9) mg/L without ECMO (p = 0.58). Extensive inter-and intrasubject variability were observed. Neither ECMO nor squared day of ECMO (saturation) were retained as significant covariates on voriconazole exposure. Conclusions: No significant ECMO-effect was observed on voriconazole exposure. A large proportion of patients had voriconazole subtherapeutic concentrations. |
format | Online Article Text |
id | pubmed-8303158 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83031582021-07-25 A Large Retrospective Assessment of Voriconazole Exposure in Patients Treated with Extracorporeal Membrane Oxygenation Van Daele, Ruth Bekkers, Britt Lindfors, Mattias Broman, Lars Mikael Schauwvlieghe, Alexander Rijnders, Bart Hunfeld, Nicole G. M. Juffermans, Nicole P. Taccone, Fabio Silvio Coimbra Sousa, Carlos Antônio Jacquet, Luc-Marie Laterre, Pierre-François Nulens, Eric Grootaert, Veerle Lyster, Haifa Reed, Anna Patel, Brijesh Meersseman, Philippe Debaveye, Yves Wauters, Joost Vandenbriele, Christophe Spriet, Isabel Microorganisms Article Background: Voriconazole is one of the first-line therapies for invasive pulmonary aspergillosis. Drug concentrations might be significantly influenced by the use of extracorporeal membrane oxygenation (ECMO). We aimed to assess the effect of ECMO on voriconazole exposure in a large patient population. Methods: Critically ill patients from eight centers in four countries treated with voriconazole during ECMO support were included in this retrospective study. Voriconazole concentrations were collected in a period on ECMO and before/after ECMO treatment. Multivariate analyses were performed to evaluate the effect of ECMO on voriconazole exposure and to assess the impact of possible saturation of the circuit’s binding sites over time. Results: Sixty-nine patients and 337 samples (190 during and 147 before/after ECMO) were analyzed. Subtherapeutic concentrations (<2 mg/L) were observed in 56% of the samples during ECMO and 39% without ECMO (p = 0.80). The median trough concentration, for a similar daily dose, was 2.4 (1.2–4.7) mg/L under ECMO and 2.5 (1.4–3.9) mg/L without ECMO (p = 0.58). Extensive inter-and intrasubject variability were observed. Neither ECMO nor squared day of ECMO (saturation) were retained as significant covariates on voriconazole exposure. Conclusions: No significant ECMO-effect was observed on voriconazole exposure. A large proportion of patients had voriconazole subtherapeutic concentrations. MDPI 2021-07-20 /pmc/articles/PMC8303158/ /pubmed/34361978 http://dx.doi.org/10.3390/microorganisms9071543 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Van Daele, Ruth Bekkers, Britt Lindfors, Mattias Broman, Lars Mikael Schauwvlieghe, Alexander Rijnders, Bart Hunfeld, Nicole G. M. Juffermans, Nicole P. Taccone, Fabio Silvio Coimbra Sousa, Carlos Antônio Jacquet, Luc-Marie Laterre, Pierre-François Nulens, Eric Grootaert, Veerle Lyster, Haifa Reed, Anna Patel, Brijesh Meersseman, Philippe Debaveye, Yves Wauters, Joost Vandenbriele, Christophe Spriet, Isabel A Large Retrospective Assessment of Voriconazole Exposure in Patients Treated with Extracorporeal Membrane Oxygenation |
title | A Large Retrospective Assessment of Voriconazole Exposure in Patients Treated with Extracorporeal Membrane Oxygenation |
title_full | A Large Retrospective Assessment of Voriconazole Exposure in Patients Treated with Extracorporeal Membrane Oxygenation |
title_fullStr | A Large Retrospective Assessment of Voriconazole Exposure in Patients Treated with Extracorporeal Membrane Oxygenation |
title_full_unstemmed | A Large Retrospective Assessment of Voriconazole Exposure in Patients Treated with Extracorporeal Membrane Oxygenation |
title_short | A Large Retrospective Assessment of Voriconazole Exposure in Patients Treated with Extracorporeal Membrane Oxygenation |
title_sort | large retrospective assessment of voriconazole exposure in patients treated with extracorporeal membrane oxygenation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303158/ https://www.ncbi.nlm.nih.gov/pubmed/34361978 http://dx.doi.org/10.3390/microorganisms9071543 |
work_keys_str_mv | AT vandaeleruth alargeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT bekkersbritt alargeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT lindforsmattias alargeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT bromanlarsmikael alargeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT schauwvlieghealexander alargeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT rijndersbart alargeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT hunfeldnicolegm alargeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT juffermansnicolep alargeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT tacconefabiosilvio alargeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT coimbrasousacarlosantonio alargeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT jacquetlucmarie alargeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT laterrepierrefrancois alargeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT nulenseric alargeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT grootaertveerle alargeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT lysterhaifa alargeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT reedanna alargeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT patelbrijesh alargeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT meerssemanphilippe alargeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT debaveyeyves alargeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT wautersjoost alargeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT vandenbrielechristophe alargeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT sprietisabel alargeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT vandaeleruth largeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT bekkersbritt largeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT lindforsmattias largeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT bromanlarsmikael largeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT schauwvlieghealexander largeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT rijndersbart largeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT hunfeldnicolegm largeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT juffermansnicolep largeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT tacconefabiosilvio largeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT coimbrasousacarlosantonio largeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT jacquetlucmarie largeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT laterrepierrefrancois largeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT nulenseric largeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT grootaertveerle largeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT lysterhaifa largeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT reedanna largeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT patelbrijesh largeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT meerssemanphilippe largeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT debaveyeyves largeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT wautersjoost largeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT vandenbrielechristophe largeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation AT sprietisabel largeretrospectiveassessmentofvoriconazoleexposureinpatientstreatedwithextracorporealmembraneoxygenation |